Category: Washington Post

The Department of Health and Human Services has recommended that marijuana be reclassified as a lower-risk Schedule III controlled substance.

The unwarranted removal of potentially millions of children is the most serious problem since states began assessing who remains eligible for Medicaid.

Find out which 10 drugs were selected for Medicare price negotiations, how they were chosen, when to expect price changes and more.

The move represents an unprecedented step in a long political war over the nation’s exorbitant drug costs.

Rocky Mountain spotted fever is on the rise in parts of Mexico and the United States. Climate change and dogs could be crucial to the fight against the tick-borne scourge.

BA.2.86 is the most mutated version of coronavirus since omicron, raising fears about re-infection. But it’s unclear whether it’s transmissible enough to surge.

Today, what to know about covid boosters, the new variant and how to protect those most at risk this fall.

He was an instrumental figure in helping amputees and paralyzed patients feel textures, temperatures and shapes through bionic devices.

Drug maker Mallinckrodt, on the hook for more than $1 billion in opioid settlement payments, plans to file for bankruptcy for a second time. The move imperils the $1.7 billion opioid settlement struck last year.

Using brain implants, machine learning and a predictive model, researchers decoded a woman’s attempts to speak at a rate that begins to approach natural conversation.